Rational Imaging

Definitive characterisation of adrenal lesions

BMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.a3092 (Published 19 January 2009)
Cite this as: BMJ 2009;338:a3092

Recent rapid responses

Rapid responses are electronic letters to the editor. They enable our users to debate issues raised in articles published on bmj.com. Although a selection of rapid responses will be included as edited readers' letters in the weekly print issue of the BMJ, their first appearance online means that they are published articles. If you need the url (web address) of an individual response, perhaps for citation purposes, simply click on the response headline and copy the url from the browser window.

Displaying 1-1 out of 1 published

Imaging phenotype is useful in characterisation of adrenal lesions, as suggested by Miller and colleagues1; however, some important points have not been addressed in their review. First, size of adrenal mass is a major predictor of malignant disease, independent of imaging characteristics. A cut-off of 4.0cm has been proposed as having the highest sensitivity (93%) in differentiating between benign and malignant tumours2. Risk of cancer is 2 % for tumours less than 4 cm and 6% for the tumours 4-6 cm in diameter. As this risk increases to 25% for tumours larger than 6 cm in diameter, most experts recommend consideration for surgery in such patients.

Second, Pheochromocytomas commonly exhibit certain imaging characteristics otherwise associated with primary adrenal carcinoma and metastasis, namely; large size, prominent vascularity, increased density (>10 Hounsfield units), cystic and haemorrhagic areas on unenhanced CT, slow delayed contrast washout (<_50 _="_" at="at" _10="_10" minutes="minutes" and="and" high="high" signal="signal" intensity="intensity" on="on" t2-weighted="t2-weighted" mri34.="mri34." biochemical="biochemical" testing="testing" should="should" therefore="therefore" be="be" routinely="routinely" done="done" in="in" all="all" patients="patients" with="with" adrenal="adrenal" mass.="mass." p="p"/> Third, adrenal insufficiency as well as adrenocortical hyperfunction should be considered in patients with bilateral adrenal masses4.

May I also add that the title “definitive characterisation of adrenal lesions” is possibly an overstatement as that can only truly be expected from a histological investigation.

References

1. Miller JC, Blake MA, Boland GWL. Definitive characterisation of adrenal lesions. BMJ 2009; 338:a3092. (24 January )

2. Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 2000; 85:637-644.

3. Motta-Ramirez GA, Remer EM, Herts BR, Gill IS, Hamrahian AH. Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. AM J Roentgenol 2005;185:684-8

4. Young WF Jr. Clinical Practice. The Incidentally discovered adrenal mass. N Engl J Med 2007; 356:6

Competing interests: None declared

Competing interests: None declared

Muhammad M Mahmood, Specialty Registrar 3

Diabetes and Endocrinology Department, Gloucestershire Royal Hospital, Gloucester. GL1 3NN

Click to like:

THIS WEEK'S POLL